TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Kubator Therapeutics AB
Closing information (x1000 EUR)
Closing information | 2024/01 | 2023/01 | 2022/01 |
Turnover |
233
|
260
|
228 |
Financial expenses |
39
|
6
|
0 |
Earnings before taxes |
127
|
154
|
78 |
EBITDA |
154
|
150
|
74 |
Total assets |
458
|
384
|
316 |
Current assets |
314
|
230
|
163 |
Current liabilities |
187
|
130
|
178 |
Equity capital |
243
|
236
|
123 |
- share capital |
4
![]() |
4
|
5 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Solvency |
53.1%
|
61.5%
|
38.9% |
Turnover per employee |
233
|
260
|
228 |
Profit as a percentage of turnover |
54.5%
|
59.2%
|
34.2% |
Return on assets (ROA) |
36.2%
|
41.7%
|
24.7% |
Current ratio |
167.9%
|
176.9%
|
91.6% |
Return on equity (ROE) |
52.3%
|
65.3%
|
63.4% |
Change turnover |
-27
|
48
|
70 |
Change turnover % |
-10%
|
22%
|
44% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.